Insider Trading activities of Kiniksa Pharmaceuticals, Ltd. (KNSA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kiniksa Pharmaceuticals, Ltd. (KNSA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kiniksa Pharmaceuticals, Ltd. since year 2005. Table 2 shows the detailed insider transactions of Kiniksa Pharmaceuticals, Ltd. since 2005. The reporting company's ticker symbol is KNSA. The reporting company's CIK number is 1730430.
The total value of stock buying since 2005 is $71,686,922.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $18,600.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Kiniksa Pharmaceuticals, Ltd. (KNSA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-10 0 $0 0 $0 10,000 $18,600
2018-05 3,912,796 $71,686,922 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Kiniksa Pharmaceuticals, Ltd. insiders (KNSA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-10-07 Paolini John F. (SVP & Chief Medical Officer) Option Ex 10,000 1.86 18,600
2018-05-29 Cormorant Global Healthcare Master Fund, Lp Buy 69,444 18.00 1,249,992
2018-05-29 Deerfield Partners, L.p. Buy 843,352 19.49 16,436,930
2018-05-29 Baker Julian (Director) Buy 3,000,000 18.00 54,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of KNSA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kiniksa Pharmaceuticals, Ltd. (symbol KNSA, CIK number 1730430) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month